Fireside Chat at ATEC2025: Building Healthcare Ventures in China

🔥 Fireside Chat at ATEC2025: Building Healthcare Ventures in China — Lessons from a 20-Year Journey

We’re excited to welcome Mark Lotter, one of the most seasoned healthcare executives and entrepreneurs operating in China, for an in-depth conversation about scaling, building, and navigating innovation in one of the world’s most complex markets.

Mark’s journey spans two decades of leadership and entrepreneurship:

🇨🇳 AstraZeneca China — led commercial operations after moving from South Africa in 2002

💊 Founder, Novamed — backed by Atlas Ventures & Fidelity; acquired by SciClone for US$100M+

🏥 COO, SciClone Pharmaceuticals

🔬 Founder & CEO, Nuance Biotech Inc — raised US$300M+, built a portfolio of commercial & developmental drug assets, now majority-owned by CBC Group

Mark will share:

💡 What it takes to build healthcare companies from scratch

📉 Lessons from scaling in China’s dynamic ecosystem

🧭 How founders can navigate regulatory, commercial, and capital challenges

🚀 His advice for the next generation of healthcare innovators

📅 ATEC2025 Finals Conference

🕓 9:00–9:30am · Friday, 5 Dec 2025

📍 Blueprint by Swire Properties

🎟️ Register NOW.

If you’re building in biotech, medtech, or healthcare innovation — this is a session you won’t want to miss.